Cellular and Molecular Life Sciences,
Год журнала:
2024,
Номер
81(1)
Опубликована: Янв. 12, 2024
Abstract
This
review
provides
an
update
on
recent
findings
from
basic,
translational,
and
clinical
studies
the
molecular
mechanisms
of
mitochondrial
dysfunction
apoptosis
hepatocytes
in
multiple
liver
diseases,
including
but
not
limited
to
alcohol-associated
disease
(ALD),
metabolic
dysfunction-associated
steatotic
(MASLD),
drug-induced
injury
(DILI).
While
ethanol-inducible
cytochrome
P450-2E1
(CYP2E1)
is
mainly
responsible
for
oxidizing
binge
alcohol
via
microsomal
ethanol
system,
it
also
metabolizing
many
xenobiotics,
pollutants,
chemicals,
drugs,
specific
diets
abundant
n-6
fatty
acids,
into
toxic
metabolites
organs,
liver,
causing
pathological
insults
through
organelles
such
as
mitochondria
endoplasmic
reticula.
Oxidative
imbalances
(oxidative
stress)
promote
covalent
modifications
lipids,
proteins,
nucleic
acids
enzymatic
non-enzymatic
mechanisms.
Excessive
changes
stimulate
various
post-translational
(PTMs)
transcription
factors,
histones.
Increased
PTMs
proteins
inactivate
enzymes
involved
reduction
oxidative
species,
acid
metabolism,
mitophagy
pathways,
leading
dysfunction,
energy
depletion,
apoptosis.
Unique
other
organelles,
control
signaling
cascades
bioenergetics
(fat
metabolism),
inflammation,
apoptosis/necrosis
hepatocytes.
When
homeostasis
shifted,
these
pathways
become
altered
or
shut
down,
likely
contributing
death
with
activation
inflammation
hepatic
stellate
cells,
fibrosis
cirrhosis.
will
encapsulate
how
contributes
hepatocyte
several
types
diseases
order
provide
recommendations
targeted
therapeutics.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Май 22, 2023
Abstract
Macrophages
exist
in
various
tissues,
several
body
cavities,
and
around
mucosal
surfaces
are
a
vital
part
of
the
innate
immune
system
for
host
defense
against
many
pathogens
cancers.
possess
binary
M1/M2
macrophage
polarization
settings,
which
perform
central
role
an
array
tasks
via
intrinsic
signal
cascades
and,
therefore,
must
be
precisely
regulated.
Many
crucial
questions
about
signaling
modulation
yet
to
uncovered.
In
addition,
clinical
importance
tumor-associated
macrophages
is
becoming
more
widely
recognized
as
significant
progress
has
been
made
understanding
their
biology.
Moreover,
they
integral
tumor
microenvironment,
playing
regulation
wide
variety
processes
including
angiogenesis,
extracellular
matrix
transformation,
cancer
cell
proliferation,
metastasis,
immunosuppression,
resistance
chemotherapeutic
checkpoint
blockade
immunotherapies.
Herein,
we
discuss
signaling,
mechanical
stresses
modulation,
metabolic
pathways,
mitochondrial
transcriptional,
epigenetic
regulation.
Furthermore,
have
broadly
extended
traps
essential
roles
autophagy
aging
regulating
functions.
discussed
recent
advances
macrophages-mediated
autoimmune
diseases
tumorigenesis.
Lastly,
targeted
therapy
portray
prospective
targets
therapeutic
strategies
health
diseases.
Nature reviews. Immunology,
Год журнала:
2021,
Номер
22(7), С. 429 - 443
Опубликована: Ноя. 5, 2021
Non-alcoholic
fatty
liver
disease
(NAFLD)
includes
a
range
of
hepatic
manifestations,
starting
with
steatosis
and
potentially
evolving
towards
non-alcoholic
steatohepatitis
(NASH),
cirrhosis
or
even
hepatocellular
carcinoma.
NAFLD
is
major
health
burden,
its
incidence
increasing
worldwide.
Although
it
primarily
disturbed
metabolism,
involves
several
immune
cell-mediated
inflammatory
processes,
particularly
when
reaching
the
stage
NASH,
at
which
point
inflammation
becomes
integral
to
progression
disease.
The
cell
landscape
diverse
steady
state
further
evolves
during
NASH
direct
consequences
for
severity.
In
this
Review,
we
discuss
current
concepts
related
role
cells
in
onset
NASH.
A
better
understanding
mechanisms
by
contribute
pathogenesis
should
aid
design
innovative
drugs
target
therapeutic
options
are
limited.
(NASH)
serious
chronic
disorder
prevalence
Metabolic
nature,
also
mobilizes
system.
Here,
Huby
Gautier
knowledge
regarding
how
subsets
affect
progression.
Cell Death and Disease,
Год журнала:
2020,
Номер
11(9)
Опубликована: Сен. 25, 2020
Abstract
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
the
most
common
cause
of
chronic
worldwide.
NAFLD
stages
range
from
simple
steatosis
(NAFL)
to
non-alcoholic
steatohepatitis
(NASH)
which
can
progress
cirrhosis
and
hepatocellular
carcinoma.
One
crucial
events
clearly
involved
in
progression
lipotoxicity
resulting
an
excessive
acid
(FFA)
influx
hepatocytes.
Hepatic
occurs
when
capacity
hepatocyte
manage
export
FFAs
as
triglycerides
(TGs)
overwhelmed.
This
review
provides
succinct
insights
into
molecular
mechanisms
responsible
for
NAFLD,
including
ER
oxidative
stress,
autophagy,
lipoapotosis
inflammation.
In
addition,
we
highlight
role
CD36/FAT
translocase
pathogenesis.
Up-to-date,
it
well
known
that
CD36
increases
FFA
uptake
and,
liver,
drives
hepatosteatosis
onset
might
contribute
its
NASH.
Clinical
studies
have
reinforced
significance
by
showing
increased
content
patients.
Interestingly,
circulating
levels
a
soluble
form
(sCD36)
are
abnormally
elevated
patients
positively
correlate
with
histological
grade
hepatic
steatosis.
fact,
induction
translocation
plasma
membrane
hepatocytes
may
be
determining
factor
physiopathology
Given
all
these
data,
targeting
or
some
functional
regulators
promising
therapeutic
approach
prevention
treatment
NAFLD.
Signal Transduction and Targeted Therapy,
Год журнала:
2020,
Номер
5(1)
Опубликована: Окт. 7, 2020
Abstract
Nicotinamide
adenine
dinucleotide
phosphate
(NADPH)
is
an
essential
electron
donor
in
all
organisms,
and
provides
the
reducing
power
for
anabolic
reactions
redox
balance.
NADPH
homeostasis
regulated
by
varied
signaling
pathways
several
metabolic
enzymes
that
undergo
adaptive
alteration
cancer
cells.
The
reprogramming
of
renders
cells
both
highly
dependent
on
this
network
antioxidant
capacity
more
susceptible
to
oxidative
stress.
Modulating
unique
might
be
effective
strategy
eliminate
these
In
review,
we
summarize
current
existing
literatures
homeostasis,
including
its
biological
functions,
regulatory
mechanisms
corresponding
therapeutic
interventions
human
cancers,
providing
insights
into
implications
targeting
metabolism
associated
mechanism
therapy.
Antioxidants,
Год журнала:
2021,
Номер
10(2), С. 174 - 174
Опубликована: Янв. 26, 2021
Oxidative
stress
(OxS)
is
considered
a
major
factor
in
the
pathophysiology
of
inflammatory
chronic
liver
diseases,
including
non-alcoholic
disease
(NAFLD).
Chronic
impairment
lipid
metabolism
closely
related
to
alterations
oxidant/antioxidant
balance,
which
affect
metabolism-related
organelles,
leading
cellular
lipotoxicity,
peroxidation,
endoplasmic
reticulum
(ER)
stress,
and
mitochondrial
dysfunction.
Increased
OxS
also
triggers
hepatocytes
pathways,
inflammation
fibrogenesis,
contributing
progression
steatohepatitis
(NASH).
The
antioxidant
response,
regulated
by
Nrf2/ARE
pathway,
key
component
this
process
counteracts
oxidative
stress-induced
damage,
restoration
normal
metabolism.
Therefore,
modulation
response
emerges
as
an
interesting
target
prevent
NAFLD
development
progression.
This
review
highlights
link
between
disturbed
context
NAFLD.
In
addition,
emerging
potential
therapies
based
on
effects
their
likely
molecular
targets
are
discussed.
Antioxidants,
Год журнала:
2020,
Номер
9(12), С. 1279 - 1279
Опубликована: Дек. 15, 2020
Activated
hepatic
stellate
cells
(HSCs)
and
myofibroblasts
are
the
main
producers
of
extracellular
matrix
(ECM)
proteins
that
form
fibrotic
tissue
leads
to
fibrosis.
Reactive
oxygen
species
(ROS)
can
directly
activate
HSCs
or
induce
inflammation
programmed
cell
death,
especially
pyroptosis,
in
hepatocytes,
which
turn
activates
fibroblasts
produce
ECM
proteins.
Therefore,
antioxidants
nuclear
factor
E2-related
factor-2
signaling
pathway
play
critical
roles
modulating
profibrogenic
response.
The
master
proinflammatory
factors
factor-κB
(NF-κB)
nucleotide-binding
oligomerization
domain
(NOD)-like
receptor
protein
3
(NLRP3)
inflammasome
may
coordinate
molecules
such
as
interleukins
1β
18,
effectively
HSCs,
large
amounts
Furthermore,
NLRP3
pro-caspase
1,
is
upregulated
by
NF-κB,
caspase
induces
pyroptosis
via
gasdermin
activation
HSCs.
ROS
central
NF-κB
pathways
IκB
(an
inhibitor
NF-κB)
thioredoxin-interacting
protein,
respectively,
thereby
linking
molecular
mechanisms
oxidative
stress,
Elucidating
these
pave
way
for
development
therapeutic
tools
interfere
with
specific
targets.
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
challenging
caused
by
multiple
factors,
which
may
partly
explain
why
it
remains
still
orphan
of
an
adequate
therapeutic
strategy.
Herein
we
focus
on
the
interplay
between
oxidative
stress
(OS)
and
other
causal
pathogenetic
factors.
Different
reactive
oxygen
species
(ROS)
generators
contribute
to
NAFLD
inflammatory
fibrotic
progression,
quite
strictly
linked
lipotoxic
injury
from
acids
and/or
wide
variety
their
biologically
active
metabolites
in
context
either
two-hit
or
(more
recent)
parallel
hits
theory.
An
antioxidant
defense
system
usually
able
protect
hepatic
cells
damaging
effects
ROS,
including
those
produced
into
gastrointestinal
tract,
i.e.,
by-products
generated
usual
cellular
metabolic
processes,
normal
dysbiotic
microbiota,
diet
through
enhanced
gut–liver
axis.
Oxidative
originating
imbalance
ROS
generation
defenses
under
influence
individual
genetic
epigenetic
factors
as
well.
Healthy
physical
activity
have
been
shown
be
effective
also
with
mechanisms,
but
compliance
these
lifestyles
very
low.
Among
several
considered
antioxidants,
vitamin
E
has
particularly
studied;
however,
data
are
contradictory.
Some
studies
natural
polyphenols
proposed
for
prevention
treatment
encouraging.
Probiotics,
prebiotics,
diet,
fecal
microbiota
transplantation
represent
new
approaches
targeting
gut
dysbiosis.
In
near
future,
precision
medicine
taking
consideration
environmental
risk
will
likely
assist
further
selecting
that
could
work
best
specific
patient.
Signal Transduction and Targeted Therapy,
Год журнала:
2022,
Номер
7(1)
Опубликована: Авг. 13, 2022
Non-alcohol-associated
fatty
liver/steatohepatitis
(NAFL/NASH)
has
become
the
leading
cause
of
liver
disease
worldwide.
NASH,
an
advanced
form
NAFL,
can
be
progressive
and
more
susceptible
to
developing
cirrhosis
hepatocellular
carcinoma.
Currently,
lifestyle
interventions
are
most
essential
effective
strategies
for
preventing
controlling
NAFL
without
development
fibrosis.
While
there
still
limited
appropriate
drugs
specifically
treat
NAFL/NASH,
growing
progress
is
being
seen
in
elucidating
pathogenesis
identifying
therapeutic
targets.
In
this
review,
we
discussed
recent
developments
etiology
prospective
targets,
as
well
pharmacological
candidates
pre/clinical
trials
patents,
with
a
focus
on
diabetes,
hepatic
lipid
metabolism,
inflammation,
Importantly,
evidence
elucidates
that
disruption
gut-liver
axis
microbe-derived
metabolites
drive
NAFL/NASH.
Extracellular
vesicles
(EVs)
act
signaling
mediator,
resulting
accumulation,
macrophage
stellate
cell
activation,
further
promoting
inflammation
fibrosis
progression
during
Targeting
gut
microbiota
or
EVs
may
serve
new
treatment
Finally,
other
mechanisms,
such
therapy
genetic
approaches,
also
have
enormous
potential.
Incorporating
different
mechanisms
personalized
medicine
improve
efficacy
better
benefit
patients
Redox Biology,
Год журнала:
2020,
Номер
36, С. 101635 - 101635
Опубликована: Июль 8, 2020
Exercise
and
dietary
intervention
are
currently
available
strategies
to
treat
nonalcoholic
fatty
liver
disease
(NAFLD),
while
the
underlying
mechanism
remains
controversial.
Emerging
evidence
shows
that
lipophagy
is
involved
in
inhibition
of
lipid
droplets
accumulation.
However,
it
still
unclear
if
exercise
improve
NAFLD
through
regulating
lipophagy,
how
skeletal
muscle
can
modulate
metabolism
liver.
Moreover,
associated
with
aging,
little
known
about
effect
accumulation
on
aging
process.
Here
vivo
vitro
models,
we
found
reduced
formation,
decreased
hepatic
triglyceride
induced
by
high-fat
diet.
enhanced
activating
AMPK/ULK1
inhibiting
Akt/mTOR/ULK1
pathways
respectively.
Furthermore,
stimulated
FGF21
production
muscle,
followed
secretion
circulation
promote
via
an
AMPK-dependent
pathway.
Importantly,
for
first
time,
demonstrated
exacerbated
which
was
ameliorated
inducing
lipophagy.
Our
findings
suggested
a
new
promoting
The
study
also
provided
support
beneficial
other
metabolic
organs
such
as
FGF21-mediated
AMPK
dependent
might
be
potential
drug
target
caused
dysfunction.